Outsmarting Cancer’s Survival Skills
A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.
MSK investigators Joan Massagué and Anna Obenauf
What Are Exceptional Responders?
When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.
Exceptional responders of new drugs in clinical trials.
Five Fascinating Approaches to Cancer Science
From tropical plants and 3-D snapshots of worms to tiny particles that light up tumors, here’s a glimpse at some of the fascinating work MSK researchers pursued in 2014 as part of our quest to advance cancer science.
Stained pathology slides of a patient’s tumor (right) and of an organoid made from that tumor (left).